Horstink, M.W., Zijlmans, J.C., Pasman, J.W., Berger, H.J. & van't Hof, M.A.
(1990) Severity of Parkinson's disease is a risk factor for peak-dose
dyskinesia. J. Neurol. Neurosurg. Psychiatry, 53, 224–226.
Iravani, M.M., Syed, E., Jackson, M.J., Johnston, L.C., Smith, L.A. &
Jenner, P. (2005) A modified MPTP treatment regime produces
reproducible partial nigrostriatal lesions in common marmosets. Eur.
J. Neurosci., 21, 841–854.
Jan, C., Pessiglione, M., Tremblay, L., Tande ́, D., Hirsch, E.C. & Franc ̧ois, C.
(2003) Quantitative analysis of dopaminergic loss in relation to functional
territories in MPTP-treated monkeys. Eur. J. Neurosci., 18, 2082–
2086.
Kish, S.J., Shannak, K. & Hornykiewicz, O. (1988) Uneven pattern of
dopamine loss in the striatum of patients with idiopathic Parkinson's disease.
Pathophysiologic and clinical implications. N. Engl. J. Med., 318, 876–
880.
Lopez, A., Munoz, A., Guerra, M.J. & Labandeira-Garcia, J.L. (2001)
Mechanisms of the effects of exogenous levodopa on the dopaminedenervated striatum. Neuroscience, 103, 639–651.
Markham, C.H. (1971) The choreoathetoid movement disorder induced by
levodopa. Clin. Pharmacol. Ther., 12, 340–343.
Melamed, E., Hefti, F., Liebman, J., Schlosberg, A.J. & Wurtman, R.J. (1980)
Serotonergic neurones are not involved in action of 1-dopa in Parkinson's
disease. Nature, 283, 772–774.
Melamed, E., Hefti, F., Pettibone, D.J., Liebman, J. & Wurtman, R.J. (1981)
Aromatic L-amino acid decarboxylase in rat corpus striatum: implications for
action of L-dopa in parkinsonism. Neurology, 31, 651–655.
Mones, R.J., Elizan, T.S. & Siegel, G.J. (1971) Analysis of L-dopa induced
dyskinesias in 51 patients with Parkinsonism. J. Neurol. Neurosurg.
Psychiatry, 34, 668–673.
Ng, K.Y., Chase, T.N., Colburn, R.W. & Kopin, I.J. (1970) L-dopa-induced
release of cerebral monoamines. Science, 170, 76–77.
Nutt, J.G. (1990) Levodopa-induced dyskinesia: review, observations, and
speculations. Neurology, 40, 340–345.
Paille, V., Brachet, P. & Damier, P. (2004) Role of nigral lesion in the genesis of
dyskinesias in a rat model of Parkinson's disease. Neuroreport, 15, 561–564.
Papapetropoulos, S., Argyriou, A.A., Ellul, J. & Chroni, E. (2004) Comparison
of motor fluctuations and L-dopa-induced dyskinesias in patients with
familial and sporadic Parkinson's disease. Eur. J. Neurol., 11, 115–119.
Pearce, R.K., Heikkila, M., Linden, I.B. & Jenner, P. (2001) L-dopa induces
dyskinesia in normal monkeys: behavioural and pharmacokinetic observations. Psychopharmacology (Berl.), 156, 402–409.
Perez-Otano, I., Oset, C., Luquin, M.R., Herrero, M.T., Obeso, J.A. & Del Rio,
J. (1994) MPTP-induced parkinsonism in primates: pattern of striatal
dopamine loss following acute and chronic administration. Neurosci. Lett.,
175, 121–125.
Rajput, A.H., Fenton, M., Birdi, S. & Macaulay, R. (1997) Is levodopa toxic to
human substantia nigra? Mov. Disord., 12, 634–638.
Snow, B.J., Vingerhoets, F.J.G., Langston, J.W., Tetrud, J.W., Sossi, V. &
Calne, D.B. (2000) Pattern of dopaminergic loss in the striatum of humans
with MPTP induced parkinsonism. J. Neurol. Neurosurg. Psychiatry, 68,
313–316.
Togasaki, D.M., Tan, L., Protell, P., Di Monte, D.A., Quik, M. & Langston,
J.W. (2001) Levodopa induces dyskinesias in normal squirrel monkeys. Ann.
Neurol., 50, 254–257.
Zoli, M. & Fuxe, L.F. (1996) Wiring and Volume transmission in the central
nervous system: the concept of closed and open synapses. Prog. Neurobiol.,
49, 363–380.
